The outlook of companies tied to blockbuster drugs like Viagra presents a nuanced investment landscape . While the initial surge of copyright, fueled by Viagra's remarkable popularity, generated substantial returns, the expiry in key markets has introduced significant risk . Investors are now grappling with the effect of rival medications , shrinki